The activation of trigeminovascular pain pathways regulates certain features of migraine pain through the release of neuropeptides such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP) at the dura mater level [25,26,27]. The gene discussed is ADCYAP1; the disease is migraine disorder.